期刊文献+

骆驼纳米抗体在医疗领域研究进展 被引量:5

Progress on Camel Nanobodies in Medical Field
暂未订购
导出
摘要 骆驼科动物体内存在一种只含重链不含轻链的天然重链抗体,克隆骆驼体内重链抗体的可变区后,得到的仅由一个重链可变区组成的单域抗体,称为纳米抗体。纳米抗体分子质量小,具有稳定性强、可溶性好、易表达、免疫原性弱、穿透性强、靶向性强、人源化简单等特点,使其在肿瘤、感染性疾病、肠炎、淀粉样变疾病、血栓以及动脉粥样硬化病变的诊断和治疗方面具有良好的应用效果,同时可以显著降低成本。基于骆驼重链抗体的VHH单域抗体的特殊结构,其在基础研究、新药的开发、疾病的诊断和治疗等方面具有广阔的前景。 Functional heavy-chain antibodies lacking light chains occur naturally in Camelidae animals. The single domain antibodyies are constructed by cloning the variable domains of heavy chain antibodies, and refferred to nanobodies. Owing to the properties like smaller size, high stability, good solubility and targe- ting effect, easy expression, low immunogenicity, great penetration, simple humanization, nanobody has great application effect in the diagnosis and therapy of tumor, infectious diseases, enteritis, amyloidosis, thrombosis and atherosclerotic lesion, meanwhile, it also reduce costs. Based on the special structure of single domain antibody that derived from heavy chain antibody, it has great application prospects in drug development, basis research and disease diagnosis and therapy.
出处 《动物医学进展》 CSCD 北大核心 2013年第3期101-105,共5页 Progress In Veterinary Medicine
基金 内蒙古科技厅科技计划项目(202063)
关键词 抗体药物 纳米抗体 重链抗体 antibody-based drug nanobody heavy chain antibody
  • 相关文献

参考文献29

  • 1Kohler G,Milstein C. Continuous cultures of fused cells secre- ting antibody of predefined specificity[J]. Nature, 1975, 256 (5517) : 495-497.
  • 2Hamers-Casterman C, Atarhouch T, Muyldermans S, et al. Naturally occurring antibodies devoid of light chains[J]. Na- ture,1993,363(6428):446-448.
  • 3Greenberg A S, Avila D, Hughes M, et al. A new antigen recep- tor gene family that undergoes rearrangement and extensive so- matic diversification in sharks[J]. Nature, 1995,374 : 168-173.
  • 4Van Der Vaart J M. Expression of VHH antibody fragments in Saccbaromyces cerevisiae [J]. Meth Mol Biol, 2002, 178 : 359- 366.
  • 5Saerens D, Conrath K, Govaert J, et al. Disulfide bond intro- duction for general stabilization of immunoglobulin heavy-chain variable domains[J]. J Mol Biol, 2008,377 (2) : 478-488.
  • 6Altintas I, Jan Kok R, Schiffelers R M. Targeting epidermal growth factor receptor in tumors: From conventional mono- clonal antibodies via heavy chain-only antibodies to nanobodies [J]. Eur J Pharmac Sci,2012(45) : 399-407.
  • 7Vincke C, Loris R, Saerens D, et al. General strategy to hu- manize a camelid single-domain antibody and identification of a universal humanized nanobody scaffold[J]. J Bio Chem, 2009, 284,3273-3284.
  • 8Aires Da Silva F, Santa-Marta M, Freitas-Vieira A, et al. Camelized rabbit-derived VH single-domain intrabodies against Vif strongly neutralize HIV-1 infectivity[J]. J Mol Biol,2004, 340(3) : 525-542.
  • 9Movahedi K, Schoonooghe S, Laoui D, et al. Nanobody-based targeting of the macrophage mannose receptor for effective in vivo imaging of tumor-associated macrophages[J]. Cancer Rea, 2012(72) :4165.
  • 10Maria J W, Lars R P, Rob C, et al. Facile labelling of an an- ti-epidermal growth factor receptor nanobody with 68Ga via a novel bifunctional desferal chelate for immuno-PET[J]. Eur J Nucl Med Mol Ima, 2011(38) :753-763.

同被引文献64

引证文献5

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部